Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02789410 · ClinicalTrials.gov registry record · NA
Spinal Morphine vs. Hydromorphone for Pain Control After Cesarean Delivery
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT02789410: Completed NA study, sponsored by Mayo Clinic.
NCT02789410 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 134 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02789410, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
Intrathecal (IT) opioids are commonly administered with local anesthetic during spinal anesthesia for post-Cesarean delivery analgesia. Traditionally, IT morphine has been used but the use of IT hydromorphone is growing. A previous study has shown that the effective dose for postoperative analgesia in 90% patients (ED90) for both IT hydromorphone and IT morphine (NCT02009722). These doses were found to be 75 mcg for hydromorphone and 150 mcg for morphine. The current proposed study would compare the duration of analgesia of IT morphine vs IT hydromorphone after elective cesarean delivery. Additionally, the investigators will compare each drug with respect the incidence of nausea and pruritus.
Interventions
- DRUG Hydromorphone
- DRUG Morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02789410
The ClinicalTrials.gov registry entry for NCT02789410 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydromorphone is the first listed.
NCT02789410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02789410 about?
NCT02789410 is a clinical study titled "Spinal Morphine vs. Hydromorphone for Pain Control After Cesarean Delivery". Intrathecal (IT) opioids are commonly administered with local anesthetic during spinal anesthesia for post-Cesarean delivery analgesia. Traditionally, IT morphine has been used but the use of IT hydromorphone is growing. A previous study has shown that the effective dose for postoperative analgesia ...
What is the current status of trial NCT02789410?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2016-05. Estimated completion is 2018-03-15.
What interventions are being tested in trial NCT02789410?
The interventions under investigation include: Hydromorphone (DRUG), Morphine (DRUG).
Who is sponsoring clinical trial NCT02789410?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.